N0n has just published a new victim: Vir Biotechnology, Inc.

ransomware.live recent, 16 November 2026

biopharmaceutical (chronic hepatitis infections) · United States | Hepatitis D and hepatitis B testing and treatment claims for a US biopharmaceutical company's franchise: 113,235,341 patient level rows covering 7,144,993 distinct patients, with ages, birth years, payer details…

Original source: ransomware.live recent